Company intelligence / Profile preview

NanoScale Systems

Manhattan, Kansas, United States

Ownership: Private
Development stage: Other

Overview

NanoScale Corporation, formerly known as NanoScale Materials, Inc., was a life science and nanotechnology company specializing in the development of advanced chemistry and nanomaterial-based products. The company focused on high-surface-area metal oxide nanoparticles designed for the neutralization of toxic chemicals, biological contaminants, and odors. Its primary commercial platform, FASTACT, was utilized by first responders and military personnel for rapid decontamination. Beyond environmental safety, NanoScale explored applications in drug delivery and wound care before its acquisition.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: NanoparticleSmall molecule
Industry: Non-Drug Biotech

Partnerships

U.S. Department of DefenseKansas State University

Beyond the preview

Go deeper on NanoScale Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoScale Systems.

Explore the full profile